Decisions That Made A Difference: Wockhardt Chief On A Life In Business

Dr Habil Khorakiwala, Wockhardt’s chair and group CEO, recounts his life and business journey, including an acquisition that went wrong, in an interview with Scrip as part of our ongoing executive profile series. Khorakiwala also outlines where he sees Wockhardt in the coming years, with the firm’s R&D thrust in the antibiotics space expected to play a pivotal role.

Habil Khorakiwala
WOCKHARDT CHAIR AND GROUP CEO DR HABIL KHORAKIWALA

Wockhardt’s founder chair and group CEO, Dr Habil Khorakiwala, believes learning from mistakes is as important as cherishing success. He has been candid enough to discuss with Scrip some of the troughs, as well as the peaks, along the corporate journey that has seen Wockhardt Ltd. emerge as a prominent Indian firm with sales of INR40.15bn ($630m) for the year ended March 2017.

In the latest instalment of our ongoing executive profile series, Khorakiwala recalls the early challenges around getting Worli Chemical Works (as the company was previously known) running and why the acquisition of

More from Leadership

More from Scrip